Reckitt Benckiser: strong technical trends led to bullish price forecast

Traders Union
All News
Financial News
Reckitt Benckiser rises 0.51% today

Highlights

Reckitt Benckiser appointed Nike's Chief Human Resources Officer, Monique Matheson, as a non-executive director effective July 1, 2024.
The company is managing the recall of its Enfamil infant formula in the US due to potential contamination, actively cooperating with regulatory authorities.
Reckitt provided updates on ongoing US legal proceedings regarding claims about its infant formula products and continues restructuring efforts to streamline operations.

Leadership changes and legal risks amid US product challenges

Reckitt Benckiser has announced the appointment of Nike’s Chief Human Resources Officer, Monique Matheson, as a non-executive director effective July 1, 2024. The company is addressing challenges from the recall of its Enfamil infant formula in the US due to potential contamination, cooperating with regulatory authorities. In addition, Reckitt has provided updates on ongoing legal proceedings in the US related to claims about its infant formula products and continues restructuring to streamline operations.

Bullish trend holds as price nears resistance levels

GBX 5,880.08 is trading above the MA-20 (GBX 5,866.60), MA-50 (GBX 5,764.72), and MA-200 (GBX 5,312.40), indicating bullish momentum in the short, medium, and long term. The nearest dynamic support sits near the Ichimoku Kijun at GBX 5,844.00, while resistance is now seen at the round level GBX 5,900 or the MA-20 area just below. Momentum remains positive, with the daily MACD signaling strong buy and ADX at 22.12 confirming a building but moderate trend. RSI sits at 53.59 and is supported by daily upward price action, while the Stoch RSI and CCI indicate lingering oversold conditions and potential for a bounce. BBP’s elevated value (4.84, overbought) shows buyers are dominating intraday, with the Awesome Oscillator neutral but not contradicting the trend. There was virtually no gap at the open, with today’s price holding near the upper end of the GBX 5,826–5,882 range. Volatility is moderate and the tone is bullish, showing persistent strength into the session highs, though some short-term oscillators suggest caution.

High upside odds as consolidation anchors weekly outlook

For the coming week, the expected price range is GBX 5,800 to GBX 5,950, keeping projections within a realistic ±2–3% band around the current price. The probability of further price increase is high (more than 80%), with a decrease seen as less likely, given three out of four weekly trend indicators are bullish. The baseline scenario is for consolidation between support at GBX 5,800 and resistance near GBX 5,950. A bullish outcome could see a breakout above GBX 5,950 if buyers maintain pressure. Conversely, a bearish scenario may play out if the price drops below GBX 5,800, exposing the next downside levels.

Viktoras Karapetjanc, expert at Traders Union, sees Reckitt Benckiser maintaining strong bullish momentum above all key moving averages. He believes that recent executive appointments and decisive responses to regulatory issues support positive sentiment around the stock. Technicals align with fundamentals, with price action supported by persistent buying and moderate volatility. If GBX 5,800 holds as support, further gains toward resistance at GBX 5,950 look likely. "Market confidence is firm here — I expect consolidation with an upward bias as long as fundamentals and price structure remain intact."

Last time, we reported that RKT was experiencing cautiously bullish momentum as it consolidated between key support and resistance. Previously it was noted that a sideways bias expected as upside breakout risk persisted amid mixed oscillator signals.

Source of Data: RKT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.